- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Dec 3, 2019
Financial News
Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron
BioCentury | Aug 21, 2019
Distillery Therapeutics
Targeting CAD or DHODH to inhibit pyrimidine synthesis for glioblastoma
BioCentury | May 20, 2019
Distillery Therapeutics
Aubagio and other DHODH inhibitors as epilepsy therapies
BioCentury | Feb 1, 2019
Product Development
Year of the lion
How 2019 milestones could see Aslan benefit from its 2012 strategy shift
BioCentury | Feb 1, 2019
Company News
Ahead of 2019 milestones, Aslan reduces headcount, operating costs
BioCentury | Jan 29, 2019
Company News
Aslan to reduce headcount, operating costs to support upcoming milestones
BioCentury | Aug 18, 2017
Company News
Aslan and Academia Sinica combine ASLAN003 and varlitinib in animal models
Items per page:
1 - 10 of 11